HIV and HCV Intervention In Drug Treatment Settings - 1
HIV and HCV Intervention in Drug Treatment Settings
1 other identifier
interventional
706
1 country
8
Brief Summary
The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Nov 2004
Shorter than P25 for phase_3
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2004
CompletedFirst Submitted
Initial submission to the registry
January 27, 2005
CompletedFirst Posted
Study publicly available on registry
January 28, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2006
CompletedJanuary 12, 2017
October 1, 2016
1.3 years
January 27, 2005
January 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HIV/HCV injection risk behaviors
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (8)
Denver Health & Hosp Authority
Denver, Colorado, 80204 4507, United States
Island Grove RTC
Greeley, Colorado, 80631, United States
SSTAR (Stanley St. Treatment & Resources, Inc)
Fall River, Massachusetts, 02720, United States
James Gilmore Jr. Treatment Center
Kalamazoo, Michigan, 49408, United States
Willamette Family Treatment Services
Eugene, Oregon, 97402, United States
SSTAR of Rhode Island - North Kingstown
North Kingstown, Rhode Island, 02852, United States
Recovery Center King Co.-Kent Detox
Kent, Washington, 98032, United States
Recovery Center King Co.-Seattle Detox
Seattle, Washington, 98144, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Booth, Ph.D.
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Purpose
- PREVENTION
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 27, 2005
First Posted
January 28, 2005
Study Start
November 1, 2004
Primary Completion
February 1, 2006
Study Completion
February 1, 2006
Last Updated
January 12, 2017
Record last verified: 2016-10